Cytotoxic Effect of Conjugates of Doxorubicin and Human Chorionic Gonadotropin (hCG) in Breast Cancer Cells-Reference-Cited by-同舟云学术

Cytotoxic Effect of Conjugates of Doxorubicin and Human Chorionic Gonadotropin (hCG) in Breast Cancer Cells

Published:2003-01 Issue:2 Volume:77 Page:125-131
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Gebauer Gerhard,Fehm Tanja,Beck Eberhard P.,Berkholz Alexander,Licht Peter,Jäger Wolfram

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.springerlink.com/index/pdf/10.1023/A:1021301001208

Reference28 articles.

1. Chabner B: Cancer Chemotherapy, Principles and Practice. J.B. Lippincott, Philadelphia, 1990

2. Magrath T: Targeted appoaches to cancer therapy. Int J Cancer 56: 163-166, 1994

3. Ehrlich P: The relationship existing between chemical constitution, distribution and pharmacological action. In: Himmelweite, Marquard M, Dale H, Elmsford (eds) The Collected Papers of Paul Ehrlich. Vol 1, Pergamon, New York, 1956, pp 596-618

4. Pastan I, Fitzgerald D: Recombinant toxins for cancer treatment. Science 254: 1173-1177, 1991

5. Yeh MW, Roffler SR, Yu MH: Doxorubicin: monoclonal antibody conjugate for therapy of human cervical cancer. Int J Cancer 51: 274-282, 1992

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective Effects of Human Chorionic Gonadotropin Against Breast Cancer: How Can We Use This Information to Prevent/Treat the Disease?;Reproductive Sciences;2016-11-15

2. Combinatorial Cytotoxic Effects of Damnacanthal and Doxorubicin against Human Breast Cancer MCF-7 Cells in Vitro;Molecules;2016-09-14

3. Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer;BMC Cancer;2012-01-03

4. Possibilities to increase the effectiveness of doxorubicin in cancer cells killing;Drug Metabolism Reviews;2011-09-26

5. Application of Reproductive Hormone Peptides for Tumor Targeting;Current Pharmaceutical Biotechnology;2011-08-01